Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID-19 vaccine

J Dermatol. 2022 Dec;49(12):e446-e447. doi: 10.1111/1346-8138.16541. Epub 2022 Jul 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Acute Generalized Exanthematous Pustulosis* / diagnosis
  • Acute Generalized Exanthematous Pustulosis* / etiology
  • COVID-19* / prevention & control
  • Drug Hypersensitivity Syndrome* / diagnosis
  • Drug Hypersensitivity Syndrome* / etiology
  • Eosinophilia* / chemically induced
  • Eosinophilia* / diagnosis
  • Humans

Substances

  • 2019-nCoV Vaccine mRNA-1273